Page 33 - தொழில்நுட்பம் பரிமாற்றம் அலுவலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hits: 1900 - Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland ROTTERDAM, The Netherlands I February 8, 2021 I Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center founded by Prof. Dr. Reno Debets (CSO) and Dr. Dora Hammerl (VP R&D), announces the closing of a seed investment and start of operations. Together with Katrien Reynders-Frederix (CEO), the team is committed to the discovery and development of novel TCR therapies against solid tumors such as triple negative breast cancer, bladder cancer, lung cancer, and glioma. Seed investors are Swanbridge Capital and Van Herk Ventures, and the Company is further awarded a Health~Holland grant for a public-private-partnership with Erasmus Medical Center.

Zuid hollandThijs spigtCillian kingVan herkReno debetsKatrien reynders frederixZealand pharmaVan herk groepTechnology transfer officeProfessor at erasmus medical centerHealth hollandErasmus medical center rotterdamErasmus medical centerCompany pan cancert launched asOnco immunology company pan cancert launchedT cell receptor